Skip to main content
. 2018 Sep 10;11:1756286418796404. doi: 10.1177/1756286418796404

Figure 2.

Figure 2.

No evidence of disease activity (NEDA) and proportion of disease activity during 12 months in the two cohorts. (a) The proportion of the cohorts with NEDA and with disease activity is also assessed by individual measures: relapse (b), EDSS progression (c), and MRI (d).

DMF, dimethyl fumarate; EDDS, Expanded Disability Status Scale; MRI, magnetic resonance imaging; TRF, teriflunomide.